Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04057118 · ClinicalTrials.gov registry record · Phase 2
A Study to Evaluate the Effectiveness and Safety of SKI-O-703 in Patients Experiencing Active Rheumatoid Arthritis Despite Treatment With Conventional Therapies.
A Phase 2 study, sponsored by Oscotec.
- Completed
- Registry status
- Phase 2
- Development phase
- 163
- Enrollment target
NCT04057118 is a Phase 2 study that has completed, run by Oscotec. The registered enrollment target is 163 participants.
The verdict
NCT04057118, a Phase 2 study, has completed, sponsored by Oscotec.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 163 participants
- Enrollment target
Study Summary
This study will evaluate the safety and efficacy of SKI-O-703 compared with placebo, in patients with active rheumatoid arthritis (RA) who have had an inadequate response to conventional synthetic disease-modifying agents. Patients will be randomly assigned to one of 4 groups and will receive one of three doses of SKI-O-703 or placebo, administered orally twice daily for 12 weeks.
Interventions
- DRUG Placebo
- DRUG SKI-O-703
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 163 participants |
| Start Date | 2019-03-20 |
| Est. Completion | 2020-10-13 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04057118
The ClinicalTrials.gov registry entry for NCT04057118 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 163 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oscotec, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04057118 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04057118 about?
NCT04057118 is a clinical study titled "A Study to Evaluate the Effectiveness and Safety of SKI-O-703 in Patients Experiencing Active Rheumatoid Arthritis Despite Treatment With Conventional Therapies.". This study will evaluate the safety and efficacy of SKI-O-703 compared with placebo, in patients with active rheumatoid arthritis (RA) who have had an inadequate response to conventional synthetic disease-modifying agents. Patients will be randomly assigned to one of 4 groups and will receive one of...
What is the current status of trial NCT04057118?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 163 participants. The study started on 2019-03-20. Estimated completion is 2020-10-13.
What interventions are being tested in trial NCT04057118?
The interventions under investigation include: Placebo (DRUG), SKI-O-703 (DRUG).
Who is sponsoring clinical trial NCT04057118?
This trial is sponsored by Oscotec, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.